Decipher prostate cancer classifier

June 15, 2016June 15, 2016

Test to Classify Metastasis Risk in Prostate Cancers Validated by Study, GenomeDx Reports

News

GenomeDx Biosciences has announced the publication of a validation study of its Decipher Prostate Cancer Classifier, a genomic test for prostate cancer (PC) designed to improve clinical decisions regarding patient treatment and risk of metastasis ... Read more

September 22, 2014September 22, 2014

GenomeDx Announces Results From New Validation Study for Decipher Prostate Cancer Classifier

News

GenomeDx Biosciences has announced its data presented at the 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO) shows significant evidence of the capacity of the Decipher® Prostate Cancer ... Read more